Home › NDC Lookup › RxCUI directory › RxCUI 984118

50 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection — RxCUI 984118

RxNorm drug concept · Semantic clinical drug
RxCUI 984118 Semantic clinical drug · SCD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI984118
Official name50 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assodium benzoate 10 % / sodium phenylacetate 10 % per 50 ML Injection; sodium benzoate 10 % / sodium phenylacetate 10 % in 50 ML Injection
FDA products mapped6
Package NDCs mapped6
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 50 ML sodium benzoate 100 MG/ML / sodium phenyla... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 50 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection RxCUI 984118

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Benzoate 70589
    • Phenylacetate 70619
    • Benzoate / phenylacetate 1008811
    • Sodium benzoate 56455
    • Sodium phenylacetate 56510
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ammonul 598000
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Benzoate / phenylacetate Injection 1731065
    • Sodium benzoate / sodium phenylacetate Injection 2647740
    • Benzoate / phenylacetate Injectable Product 1152009
    • Sodium benzoate / sodium phenylacetate Injectable Product 2662540
    • Benzoate / phenylacetate Injection [Ammonul] 1731067
    • Sodium benzoate / sodium phenylacetate Injection [Ammonul] 2654275
    • Ammonul Injectable Product 1173506
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Sodium benzoate 100 MG/ML 984116
    • Sodium phenylacetate 100 MG/ML 984117
    • 50 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection [Ammonul] 984120
    • Sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML [Ammonul] 984119

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sodium benzoate 100 MG/ML SCDC · 984116
  • Sodium phenylacetate 100 MG/ML SCDC · 984117
  • Benzoate / phenylacetate Injection SCDF · 1731065
  • Sodium benzoate / sodium phenylacetate Injection SCDFP · 2647740
  • Benzoate / phenylacetate Injectable Product SCDG · 1152009
  • Sodium benzoate / sodium phenylacetate Injectable Product SCDGP · 2662540

Brand-Name Concepts

  • 50 ML sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML Injection [Ammonul] SBD · 984120
  • Sodium benzoate 100 MG/ML / sodium phenylacetate 100 MG/ML [Ammonul] SBDC · 984119
  • Benzoate / phenylacetate Injection [Ammonul] SBDF · 1731067
  • Sodium benzoate / sodium phenylacetate Injection [Ammonul] SBDFP · 2654275
  • Ammonul Injectable Product SBDG · 1173506
  • Ammonul BN · 598000

📦 FDA Products & Package NDCs

6 products · 6 package NDCs
6 package NDCs map to RxCUI 984118 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
68382-0396-01 1 VIAL in 1 CARTON (68382-396-01) / 50 mL in 1 VIAL SODIUM PHENYLACETATE AND SODIUM BENZOATE Zydus Pharmaceuticals USA Inc. 2021-02-08
68475-0001-50 1 VIAL in 1 CARTON (68475-001-50) / 50 mL in 1 VIAL Sodium Phenylacetate and sodium benzoate Navinta LLC 2021-03-04
70511-0101-50 1 VIAL, SINGLE-DOSE in 1 CARTON (70511-101-50) / 50 mL in 1... SODIUM PHENYLACETATE AND SODIUM BENZOATE MAIA PHARMACEUTICALS, INC 2017-05-22
70556-0100-50 1 VIAL, SINGLE-DOSE in 1 CARTON (70556-100-50) / 50 mL in 1... SODIUM PHENYLACETATE and SODIUM BENZOATE Ailex Pharmaceuticals, LLC 2016-02-26
81665-0203-01 1 VIAL, SINGLE-DOSE in 1 CARTON (81665-203-01) / 50 mL in 1... SODIUM PHENYLACETATE and SODIUM BENZOATE Omnivium Pharmaceuticals LLC 2025-02-25
81665-0204-01 1 VIAL, SINGLE-DOSE in 1 CARTON (81665-204-01) / 50 mL in 1... SODIUM PHENYLACETATE and SODIUM BENZOATE Omnivium Pharmaceuticals LLC 2025-05-15
Observed labelers: Omnivium Pharmaceuticals LLC (2) · Ailex Pharmaceuticals, LLC (1) · MAIA PHARMACEUTICALS, INC (1) · Navinta LLC (1) · Zydus Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.